Mraz Amerine & Associates Inc. Purchases 1,369 Shares of Nutrien Ltd. (NYSE:NTR)

Mraz Amerine & Associates Inc. boosted its position in Nutrien Ltd. (NYSE:NTRFree Report) by 8.0% in the fourth quarter, HoldingsChannel.com reports. The firm owned 18,535 shares of the company’s stock after acquiring an additional 1,369 shares during the period. Mraz Amerine & Associates Inc.’s holdings in Nutrien were worth $1,044,000 as of its most recent SEC filing.

Other large investors have also added to or reduced their stakes in the company. Townsend & Associates Inc raised its holdings in Nutrien by 27.8% in the third quarter. Townsend & Associates Inc now owns 163,942 shares of the company’s stock worth $10,125,000 after purchasing an additional 35,690 shares in the last quarter. CIBC Asset Management Inc raised its holdings in Nutrien by 2.5% in the third quarter. CIBC Asset Management Inc now owns 6,361,084 shares of the company’s stock worth $394,047,000 after purchasing an additional 154,159 shares in the last quarter. Canoe Financial LP grew its stake in shares of Nutrien by 64.6% during the third quarter. Canoe Financial LP now owns 75,945 shares of the company’s stock worth $4,690,000 after acquiring an additional 29,819 shares during the last quarter. First Eagle Investment Management LLC grew its stake in shares of Nutrien by 0.5% during the third quarter. First Eagle Investment Management LLC now owns 9,262,659 shares of the company’s stock worth $572,062,000 after acquiring an additional 48,230 shares during the last quarter. Finally, Deutsche Bank AG grew its stake in shares of Nutrien by 1.5% during the third quarter. Deutsche Bank AG now owns 14,708,135 shares of the company’s stock worth $908,374,000 after acquiring an additional 214,299 shares during the last quarter. 63.10% of the stock is currently owned by institutional investors.

Wall Street Analysts Forecast Growth

A number of equities research analysts recently commented on the company. HSBC dropped their target price on Nutrien from $63.00 to $57.00 and set a “hold” rating on the stock in a research report on Friday, March 8th. Wolfe Research assumed coverage on Nutrien in a research report on Friday, March 1st. They issued an “outperform” rating and a $66.00 target price on the stock. The Goldman Sachs Group dropped their target price on Nutrien from $88.00 to $78.00 and set a “buy” rating on the stock in a research report on Thursday, February 1st. Wells Fargo & Company reduced their target price on Nutrien from $77.00 to $69.00 and set an “overweight” rating for the company in a research note on Monday, February 26th. Finally, JPMorgan Chase & Co. downgraded Nutrien from a “neutral” rating to an “underweight” rating and reduced their target price for the stock from $58.00 to $48.00 in a research note on Friday, February 23rd. Two investment analysts have rated the stock with a sell rating, six have given a hold rating and eleven have assigned a buy rating to the stock. According to data from MarketBeat.com, the company has a consensus rating of “Hold” and an average target price of $67.95.

Read Our Latest Research Report on NTR

Nutrien Trading Up 0.3 %

Shares of NTR traded up $0.14 during midday trading on Wednesday, reaching $51.81. The company had a trading volume of 1,252,589 shares, compared to its average volume of 2,051,746. Nutrien Ltd. has a 1-year low of $47.90 and a 1-year high of $75.29. The stock has a market cap of $25.62 billion, a PE ratio of 20.42, a price-to-earnings-growth ratio of 1.91 and a beta of 0.89. The firm has a 50 day simple moving average of $52.80 and a 200-day simple moving average of $54.39. The company has a quick ratio of 0.65, a current ratio of 1.17 and a debt-to-equity ratio of 0.35.

Nutrien (NYSE:NTRGet Free Report) last released its quarterly earnings results on Wednesday, February 21st. The company reported $0.37 earnings per share for the quarter, missing analysts’ consensus estimates of $0.72 by ($0.35). The business had revenue of $5.66 billion for the quarter, compared to analysts’ expectations of $5.36 billion. Nutrien had a return on equity of 8.59% and a net margin of 4.33%. The business’s revenue for the quarter was down 24.8% compared to the same quarter last year. During the same quarter in the prior year, the company posted $2.02 earnings per share. Research analysts forecast that Nutrien Ltd. will post 3.91 EPS for the current fiscal year.

Nutrien Increases Dividend

The company also recently announced a quarterly dividend, which was paid on Thursday, April 11th. Shareholders of record on Thursday, March 28th were given a $0.54 dividend. This is an increase from Nutrien’s previous quarterly dividend of $0.53. This represents a $2.16 annualized dividend and a yield of 4.17%. The ex-dividend date of this dividend was Wednesday, March 27th. Nutrien’s payout ratio is currently 85.38%.

Nutrien Profile

(Free Report)

Nutrien Ltd. provides crop inputs and services. The company operates through four segments: Retail, Potash, Nitrogen, and Phosphate. The Retail segment distributes crop nutrients, crop protection products, seeds, and merchandise products. The Potash segment provides granular and standard potash products.

Further Reading

Want to see what other hedge funds are holding NTR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Nutrien Ltd. (NYSE:NTRFree Report).

Institutional Ownership by Quarter for Nutrien (NYSE:NTR)

Receive News & Ratings for Nutrien Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nutrien and related companies with MarketBeat.com's FREE daily email newsletter.